Searchable abstracts of presentations at key conferences in endocrinology

ea0035p673 | Growth hormone IGF axis basic | ECE2014

Incidence and late prognosis of acromegaly in Denmark: preliminary data

Dal Jakob , Feldt-Rasmussen Ulla , Andersen Marianne , Kristensen Lars , Laurberg Peter , Sorensen Henrik , Jorgensen Jens Otto

Introduction: Acromegaly is a rare disease caused by GH hypersecretion from a pituitary adenoma. However, accurate estimates of incidence and prevalence are scarce and not based on nationwide populations. It is well known that surgical cure may normalize mortality and improve morbidity but similar data are not available for patients receiving medical treatment.Method: We first validated the ICD-8 and ICD-10 diagnosis codes for acromegaly in The National ...

ea0032p875 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Thirty-day mortality in acute non-surgical patients admitted with hyponatremia

Holland-Bill Louise , Christiansen Christian , Ring Troels , Toft Sorensen Henrik , Lunde Jorgensen Jens Otto

Introduction: Hyponatremia (serum sodium ≤135 mmol/l), the most common electrolyte disorder encountered, has been associated with increased mortality in patients with particularly cancer, heart failure, chronic kidney and liver disease. However, evidence of the clinical implications in broader populations is scarce, and uncertain due to confounding from preexisting disease. We aimed to examine the association between admission-hyponatremia and 30-day mortality in acute n...

ea0049gp17 | Adrenal 2 | ECE2017

Hypercortisolism is prevalent in newly diagnosed type 2 diabetes: a prospective study of 384 consecutive patients

Steffensen Charlotte , Dekkers Olaf M , Lyhne Johanne , Poulsen Per L , Rungby Jorgen , Sorensen Henrik T , Jorgensen Jens Otto L

Background: Cross-sectional studies in small and selected populations indicate a relatively high prevalence of incipient and/or subclinical Cushing’s syndrome (CS) in patients with type 2 diabetes (T2D), which could have therapeutic implications.Aim: To estimate the prevalence of CS in a large, unselected cohort of recently diagnosed T2D patients.Methods: A total of 384 consecutive out – patients with T2D diagnosed after ...

ea0032p352 | Diabetes | ECE2013

Increased alanine aminotransferase levels and associated characteristics among newly diagnosed type 2 diabetes patients: results from the DD2 study

Thomsen Reimar , Mor Anil , Rungby Jorgen , Ulrichsen Sinna , Nielsen Jens , Stidsen Jacob , Friborg Soren , Brandslund Ivan , Christiansen Jens , Beck-Nielsen Henning , Sorensen Henrik

Objectives: There is limited knowledge of high-sensitivity C-reactive protein (CRP) levels among newly diagnosed T2D patients in the population-based setting, and of factors associated with elevated CRP.Methods: Measurements of CRP were performed in the first 1036 T2D patients in the nationwide DD2 project, enrolling new T2D patients from general practitioners and hospital specialist outpatient clinics. We examined the number of T2D patients within CRP t...

ea0032p358 | Diabetes | ECE2013

Increased alanine aminotransferase levels and associated characteristics among newly diagnosed type 2 diabetes patients: results from the DD2 study

Mor Anil , Thomsen Reimar , Rungby Jorgen , Ulrichsen Sinna , Nielsen Jens , Stidsen Jacob , Friborg Soren , Brandslund Ivan , Christiansen Jens , Beck-Nielsen Henning , Sorensen Henrik

Objectives: Elevated levels of serum alanine aminotransferase (ALAT) have been linked with non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), insulin resistance and the metabolic syndrome in type 2 diabetes (T2D) patients. We examined ALAT levels in newly diagnosed T2D patients, and the factors associated with such elevation.Methods: Measurements of ALAT were performed in 1025 (43% women and 57% men) new T2D patients enrolle...

ea0032p380 | Diabetes | ECE2013

High prevalence of the metabolic syndrome among newly diagnosed type 2 diabetes patients in Denmark

Nielsen Jens Steen , Thomsen Reimar W , Ulrichsen Sinna Pilgaard , Mor Anil , Stidsen Jacob Volmer , Rungby Jorgen , Friborg Soren , Brandslund Ivan , Christiansen Jens Sandahl , Toft-Sorensen Henrik , Beck-Nielsen Henning

Few population-based data exist on the prevalence of the metabolic syndrome (MS) its components, and its association with subclinical inflammation and insulin resistance among patients newly diagnosed with type two diabetes (T2D).We examined the MS according to IDF criteria by linkage primary data (waist circumference, fasting blood glucose, and high-sensitivity C-reactive protein (CRP)) with variables from the Danish diabetes database for adults (blood ...

ea0099p12 | Adrenal and Cardiovascular Endocrinology | ECE2024

How to assess adrenal function during low dose prednisolone treatment – impact of a 1- vs 2-day prednisolone pause before the ACTH test: Results from the Double Edge-Rescue Study

Willemoes Borresen Stina , Hansen SimonBoggild , Al-Jorani Hajir , Bislev LiseSofie , Boesen VictorBrun , Christensen LouiseLehmann , Feldt-Rasmussen Ulla , Dreyer AnjaFenger , Glintborg Dorte , Jensen RichardChristian , Jorgensen NannaThurmann , Lund MarieLouise , Okutan Sema , Stankovic Jelena , Tei Randi , Hetland MereteLund , Locht Henning , Hauge Ellen , Keller Kresten , Just SorenAndreas , Voss Anne , Sorensen Henrik Toft , Stewart Paul M. , Jorgensen JensOtto , Andersen Marianne , Klose Marianne

Background: Correctly identifying glucocorticoid-induced adrenal insufficiency in patients tapering prednisolone treatment to ≤5 mg daily is crucial. Pausing prednisolone before an ACTH-test is standard, yet the optimal pause duration is uncertain.Aim: To determine the outcome of an ACTH-test after 1 vs 2 days’ prednisolone pause before the test.Methods: Baseline data from an ongoing randomised clinical trial (EudraCT:20...

ea0099p228 | Adrenal and Cardiovascular Endocrinology | ECE2024

Impact of glucocorticoid-induced adrenal insufficiency on health-related quality of life in patients receiving long-term low dose prednisolone treatment: Results from the double edge-rescue trial

Lund Marie Louise , Al-Jorani Hajir , Stankovic Jelena , Bislev Lise Sofie , Bjorner Jakob Bue , Boesen Victor Brun , Christensen Louise Lehmann , Feldt-Rasmussen Ulla , Dreyer Anja Fenger , Glintborg Dorte , Hansen Annette , Hansen Simon Boggild , Jensen Richard Christian , Jorgensen Nanna Thurmann , Klose Marianne , Locht Henning , Tei Randi , Watt Torquil , Stewart Paul M. , Sorensen Henrik Toft , Jorgensen Jens Otto , Andersen Marianne , Borresen Stina Willemoes

Objectives: The clinical impact of glucocorticoid-induced adrenal insufficiency in patients on low-dose prednisolone is unclear. We investigated the influence of adrenal function on health-related quality of life (HRQoL) in patients tapering prednisolone.Method: Baseline data from an ongoing prospective randomised clinical trial including 278 patients with polymyalgia rheumatica/giant cell arteritis treated with prednisolone for ≥12 weeks, current ...

ea0099rc11.5 | Rapid Communications 11: Adrenal and Cardiovascular Endocrinology | Part II | ECE2024

Assessment of adrenal function after prednisolone treatment in patients with polymyalgia rheumatica and/or giant cell arteritis – Data from the double edge-replace study

Boggild Hansen Simon , Fenger Dreyer Anja , Jorgensen Nanna Thurmann , Al-Jorani Hajir , Sofie Bislev Lise , Boesen Victor Brun , Borresen Stina Willemoes , Christensen Louise Lehmann , Glintborg Dorte , Hamge Ellen , Hetland Merete Lund , Jensen Richard Christian , Just Soren Andreas , Keller Kresten , Klose Marianne , Lamgesen Kristina , Lund Marie Louise , Stankovic Jelena , Stewart Paul M , Sorensen Henrik Toft , Tei Randi , Voss Anne , Feldt-Rasmussen Ulla , Jorgensen Jens Otto , Andersen Marianne

Introduction: Pharmacological glucocorticoid (GC) treatment may cause iatrogenic adrenal insufficiency (GIA), although the prevalence and clinical implications are debated. With 3% of the Danish population redeeming prescriptions of systemic GC annually, the number of patients at risk is potentially extensive. Taken together, there is an unmet need for a prospective and unbiased assessment of the GIA prevalence.Materials and Methods: The data for this re...